Drug Discovery Articles
ChemBridge and CRL to collaborate with AstraZeneca
25 September 2006
David Brister joins Evotec as CBO
25 September 2006
UK govt funding for VASTox' stem cell program
25 September 2006
AstraZeneca opens two new UK labs
25 September 2006
ExonHit's 1st-half sales rise 48% to 3.2M euros
25 September 2006
NuCana gets novel cancer agents
25 September 2006
Xceleron welcomes data from CREAM microdosing study
18 September 2006
Pharmacopeia earns milestone from S-P
18 September 2006
Graffinity and Boeh-Ing agree research deal
18 September 2006
Invitrogen acquires fluo product lines
18 September 2006
Galapagos and OneWorld agree drug discovery deal
11 September 2006
Evotec takes over ChemAxon product line
11 September 2006
Zealand Pharma raises cash for R&D
11 September 2006
Invitrogen to buy Sentigen for $25.9M
11 September 2006
Genetix signs definitive agreement to buy AI
11 September 2006
Evotec and CHDI to collaborate on HD drug development
14 August 2006
EVT101 completes Ph I AD study, says Evotec
14 August 2006
Galapagos' 1st-half 2006 loss improves 31%
14 August 2006
Predix gets $1.5M milestone from CFFT
14 August 2006
India's Orchid buys out rest of Bexel
14 August 2006
Servier extends deal with Tripos
7 August 2006
GSK enters B-RAF accord with UK research groups
31 July 2006
Argenta in new accord with AstraZeneca
31 July 2006
Evotec sells core detection technology IP to Olympus
26 July 2006
1.8M-euro grant for Galapagos
26 July 2006
Galapagos and Cellzome enter kinase drug R&D accord
24 July 2006
BioWisdom and AstraZeneca extend agreement
24 July 2006
Celera identifies gene linked to AD
24 July 2006
Japan stock market week to July 10, 2006
17 July 2006
Aureus licenses AurSCOPE to Xention
17 July 2006
Axaron/LION to form new CNS drugmaker
17 July 2006
Asterand in drug discovery deal for Japan
17 July 2006
ImmuPharma's lupus drug enters Ph II
17 July 2006
Galapagos NV acquires DPI's discovery operations
10 July 2006
InPharmatica licenses AI to Eli Lilly & Co
10 July 2006
Roche and Evotec talk biotech partnering
19 June 2006
Proximagen licenses candidate CNS drugs
5 June 2006
Synairgen's IFNB as potential COPD drug
5 June 2006
Comgenex boosts Albany Molecular revenues
29 May 2006
Pharmacopeia and Cephalon alliance
29 May 2006
deCODE, Illumina enter diagnostics accord
22 May 2006
Medicure raises $25M in placing
15 May 2006
FDA clears Astex' IND for novel cancer drug
1 May 2006
Lectus acquires NeuroServe assets
24 April 2006
deltaDOT raises $10.5M in private financing
17 April 2006
Ablynx to extend Procter & Gamble Pharma R&D accord
17 April 2006
Evotec to set up $2.8M US screening center
17 April 2006
Lannett and Azad forge drug discovery accord
3 April 2006
Galapagos and Arthrogen sign drug discovery deal
3 April 2006
DTI grant for MNLpharma's sugar adjuvant technology
27 March 2006
Inpharmatica and Ingenuity to offer joint services
27 March 2006
GPC sees losses increase 56% in FY 2005
27 March 2006
CytRx's RNAi program sees progress in 2006
20 March 2006
Serologicals buys UK firm Cytomyx for around $7M
20 March 2006
Pharmacopeia and Neurocrine expand accord
20 March 2006
Alizyme loss grows
20 March 2006
Dyax makes $30M placing
13 March 2006
Antisoma enters R&D accord with EcoBiotics
13 March 2006
Japan stock market week to March 6, 2006
13 March 2006
Galapagos' 2005 income up 44% with BioFocus
13 March 2006
Thomson launches brand management tool
13 March 2006
Resistance to change impacts e-clinical trials tech uptake
27 February 2006
2nd research accord for Graffinity and Mutabilis
27 February 2006
Opsona and Wyeth sign drug development accord
20 February 2006
Sun Pharma to form new separate R&D group
20 February 2006
GSK buys Pliva Research Inst for $50M
20 February 2006
Cambrex to buy US skin specialists Cutanogen
13 February 2006
Pharmacopeia gets $50M Celgene milestone
13 February 2006
Arrow's A-831 enters preclinical development
13 February 2006
Dr Reddy's/Argenta sign COPD drug accord
13 February 2006
Albany Molecular Research buys ComGenex
6 February 2006
Evotec and Cellomics sign collaboration deal
6 February 2006
SuperGen to buy Montigen for $18 M
6 February 2006
Open BioSystems debuts Lentiviral shRNAmir library
30 January 2006
Pfizer licenses Astex' P450 IP
30 January 2006
Organon and Shanghai Genomics' research collaboration
30 January 2006
Tripos enters new partnerships
30 January 2006
JPMA issues guidelines for research tool patent
30 January 2006
NextGen raises $3.4 M upon entry to the AIM
30 January 2006
ImmuPharma joins London's AIM
30 January 2006
Funding to advance Axordia's stem cell programs
30 January 2006
Japan stock market week to Jan 23
30 January 2006
Bayer to pay up to $385M for ex-US sale rights to Nuvelo's Ph III thrombolytic, alfimeprase
16 January 2006
Santherha completes MBO of Graffinity
16 January 2006
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
